Moderna misses on 3Q, shaves 2022 vaccine expectations

Nov 3, 2022, 5:14 AM | Updated: 3:05 pm

Supply problems have again forced Moderna to delay some COVID-19 vaccine deliveries, a move that surprised Wall Street and contributed to a disappointing third quarter.

The vaccine developer said Thursday that short-term issues prompted it to shift some deliveries initially planned for this year into 2023. It now expects 2022 revenue from advance purchase agreements to be as much as $3 billion lower than what it had forecast in August.

CEO Stephane Bancel told analysts on a call to discuss the quarter that the company was dealing with complex manufacturing issues. They included switching from 10-dose vials to five doses, the launch of a new booster and providing two different boosters globally.

He said the company was working on some “robust fixes” so it would be in better shape for end-of-the-year production next fall.

“We’ve had quite a number of pain points,” Bancel said.

Last year, Moderna also scaled back expectations for COVID-19 vaccine deliveries in the third quarter due to supply issues. Bancel said then that the problems were short-term and can be fixed.

On Thursday, the company said it now expects between $18 billion and $19 billion in revenue from advance purchase agreements this year. That’s down from the approximately $21 billion it forecast in August.

That shift was unexpected, Cowen analyst Tyler Van Buren said in a research note. He added that the company’s $4.5 billion to $5.5 billion in confirmed advanced purchase agreements for 2023 also was well below average Wall Street expectations.

Company leaders said on the call with analysts that the 2023 range was a floor. They expect to add more contracts.

Moderna’s Spikevax is the company’s main source of revenue, outside of grants and money from collaborations. Vaccine sales slid 35% in the recently completed third quarter to $3.12 billion while total revenue tumbled to $3.36 billion.

Moderna’s net income fell 69% to $1.04 billion, and earnings per share totaled $2.53.

Analysts were looking for earnings of $3.30 per share on $3.53 billion in revenue, according to FactSet.

Rival vaccine maker Pfizer Inc. said last month that it will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots. That’s expected to happen next year.

Moderna leaders on Thursday did not detail how much the company will charge for Spikevax. They said the price would reflect guidelines for cost effectiveness set by global health authorities.

Shares of Cambridge, Massachusetts-based Moderna Inc. added less than 1% to $150.07 Thursday morning while broader indexes slid.


Follow Tom Murphy on Twitter: @thpmurphy

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Tracy Toulou...

Associated Press

How to tackle crime in Indian Country? Empower tribal justice, ex-Justice Department official says

A recently retired director of the Justice Dept. says the federal government hasn't given tribal justice systems equal recognition.

54 minutes ago

Speaker of the House Mike Johnson...

Associated Press

House Speaker Mike Johnson says he will push for aid to Israel and Ukraine this week

House Speaker Mike Johnson said Sunday he will try to advance wartime aid for Israel this week, along with funding for Ukraine.

2 hours ago

President Joe Biden speaks at a campaign rally Saturday, March 9, 2024, at Pullman Yards in Atlanta...

Associated Press

US shoots down ‘nearly all’ Iran-launched attack drones as Biden vows support for Israel’s defense

Joe Biden cut short a weekend stay at his beach house to meet with his national security team as Iran launched an attack against Israel.

1 day ago

Protesters in Phoenix shout as they join thousands marching around the Arizona state Capitol after ...

Associated Press

Abortion ruling supercharges Arizona to be an especially important swing state

A ruling this week instituting a near-total abortion ban supercharged Arizona's role, turning it into the most critical battleground.

2 days ago

Former President Donald Trump, center, appears in court for his arraignment, Tuesday, April 4, 2023...

Associated Press

Manhattan court searching for jurors to hear first-ever criminal case against a former president

Jury selection is set to start Monday in former President Donald Trump's hush money case — the first trial of the presumptive nominee.

2 days ago

Emergency personnel arrive on the scene after a  an 18-wheeler crashed into the Texas Department of...

Associated Press

1 dead and 13 injured in semitrailer crash at a Texas public safety office, with the driver jailed

A driver rammed an 18-wheeler though the front of a building where his renewal for a commercial driver’s license had been rejected.

2 days ago

Sponsored Articles



Desert Institute for Spine Care is the place for weekend warriors to fix their back pain

Spring has sprung and nothing is better than March in Arizona. The temperatures are perfect and with the beautiful weather, Arizona has become a hotbed for hikers, runners, golfers, pickleball players and all types of weekend warriors.


Day & Night Air Conditioning, Heating and Plumbing

Day & Night is looking for the oldest AC in the Valley

Does your air conditioner make weird noises or a burning smell when it starts? If so, you may be due for an AC unit replacement.


Day & Night Air Conditioning, Heating and Plumbing

Valley residents should be mindful of plumbing ahead of holidays

With Halloween in the rear-view and more holidays coming up, Day & Night recommends that Valley residents prepare accordingly.

Moderna misses on 3Q, shaves 2022 vaccine expectations